Nath Bio-Genes (India) Ltd Share Price

FMCG

NSE: NATHBIOGEN Small Cap ISIN: INE448G01010

As on 13 June 2026 at 01:11 IST

₹167.59

+ 2.16

(1.31%)

Sell Buy

Over 1 Month

-2%

Over 6 Months

Over 1 Year

-18.87%

Over 3 Years

-12.03%

Nath Bio-Genes (India) Ltd Summary

Close ₹165.43

Open ₹168.07

High ₹169

Low ₹164.55

Volume 4,624

Net Turnover (in Cr) ₹0.077

52Wk High ₹238.69

52Wk Low ₹126.15

52Wk High / Low

126.15

238.69

Nath Bio-Genes (India) Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹314.38

EPS (TTM) 20.52

Book Value (BV) 362.75

Div. Yield 1.21 %

P/E (TTM) 7.06

Price/Book Value 0.45

Delivery % 64.10 %

Face Value 10

Key Ratios

PE Ratio 6.58

PB Ratio 0.43

EV to Sales 0.83

PEG Ratio 1.35

ROA 5.52

ROE 6.69

Debt-Equity 0.17

Net Profit Margin 11.63

Operating Profit Margin 15.92

Nath Bio-Genes (India) Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2013
Total Revenue	369.45	333.25	301.92	280.22	138.28
Total Expenses	329.41	295.14	265.75	254.87	125.99
Profit Before Tax	40.58	41.56	36.16	-63.43	12.30
Profit After Tax	38.60	39.62	35.01	-67.39	11.75
Operating Profit After Depreciation	50.53	47.23	46.29	35.96	15.97

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2013
Fixed Assets	250.38	249.46	244.38	244.89	37.63
Total Non Current Assets	336.20	308.57	271.97	271.72	38.53
Total Current Assets	690.01	571.66	520.83	467.77	119.75
Total Assets	1,026.21	880.23	792.80	739.49	158.28
Total Shareholder's Fund	644.39	609.92	573.17	541.93	57.47

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash From Operating Activities	17.58	74.59	38.37	17.05
Net Cash Used In Investing Activities	-3.96	-27.40	-2.88	-19.85
Net Cash Used In Financing Activities	-2.13	-7.78	-1.67	-22.23

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	367.04	333.28	301.85	280.22	309.23
Total Expenses	323.45	294.60	265.53	254.82	252.48
Profit Before Tax	44.12	42.12	36.32	-63.39	56.75
Profit After Tax	42.14	40.18	35.17	-67.34	55.66
Operating Profit After Depreciation	53.23	47.78	46.44	36.01	65.57

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	250.22	249.45	244.38	244.89	246.93
Total Non Current Assets	336.32	308.57	271.98	271.74	265.62
Total Current Assets	680.55	568.52	520.99	467.80	523.89
Total Assets	1,016.87	877.08	792.97	739.54	789.51
Total Shareholder's Fund	648.67	610.66	573.35	541.97	613.28

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	26.80	74.72	38.37	17.05	1.11
Net Cash Used In Investing Activities	-4.05	-27.40	-2.88	-19.87	-10.28
Net Cash Used In Financing Activities	-10.62	-9.81	-1.67	-22.23	16.40

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	51.59	65.96	43.85	283.70	51.97
Total Expenses	47.11	62.38	37.74	245.41	51.56
Profit Before Tax	2.50	2.49	5.45	37.93	2.10
Profit After Tax	-0.01	1.60	4.82	37.28	1.48
Operating Profit after Depreciation	6.86	5.32	8.04	40.05	4.27

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	45.69	65.96	39.77	280.17	49.37
Total Expenses	39.08	57.12	32.58	241.26	46.20
Profit Before Tax	6.29	8.11	4.84	38.86	5.33
Profit After Tax	3.79	7.23	4.20	38.21	4.71
Operating Profit after Depreciation	8.99	10.58	9.12	40.67	7.21

Nath Bio-Genes (India) Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 163.65

S2 161.88

S3 159.20

Pivot 166.33

R1 168.10

R2 170.78

R3 172.55

Moving Average

20 SMA 169.16

50 SMA 165.96

100 SMA 155.71

200 SMA 159.79

Nath Bio-Genes (India) Ltd Corporate Actions

Nath Bio-Genes (India) Ltd

₹2.0/Share

Announcement Date 14 Aug 2025

Record Date 14 Aug 2025

Div Yield 20%

AGM Date: 27 Aug 2021

AGM 27/08/2021 Book closure for upcoming Annual General Meeting (As per BSE Announcement Dated on 24/06/2021) The Outcome of Shareholders Meeting held on 27th August 2021 1. Proceedings of Annual General Meeting. 2. Voting Results for the AGM. 3. Scrutinizers Report for the Annual General Meeting. (As Per BSE Announcement Dated on 8/28/2021 3:23:38 AM)

AGM Date: 30 Jun 2022

Outcome of Board Meeting held on 30th May 2022 Approved and Fix the date of Annual General Meeting of the Company to be held on Thursday 30th June 2022 at 11.00 am through video conference/other audio visual means accordance with the applicable circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. 1. Proceddings of Annual General Meeting held on 30th June 2022. 2. Voting Results 3. Scrutinizers Report. (As Per BSE Announcement dated on 30.06.2022)

AGM Date: 11 Jul 2023

The outcome of the Board Meeting held on 22nd April 2023. Approved and Fix the date of Annual General Meeting of the Company to be held on Friday 30th June 2023 at 11.00 am through video conference/other audio visual means accordance with the applicable circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. Approved the closure of the Register of Members of the Company from 25th June 2023 to 30th June 2023 (both days inclusive for the purpose of AGM). Book Closure and record date for upcoming AGM (As per BSE Announcement Dated on 25/04/2023) Intimation for Change in Date of Annual General Meeting Intimation for Change in Book Closure and Record Date (As Per BSE Announcement dated on 23.05.2023) Notice of 30th Annual General Meeting and Annual Report for FY23. (As Per BSE Announcement Dated on 17.06.2023) we informed you that the 30th AGM of the Company was held on Tuesday, 11th July 2023 at 11.00 AM, in this regard the Company Submitting the following 1. Proceedings of 30th Annual General Meeting. 2. Voting Results as per Regulation 44 (3). 3. Scrutinizers Report. Outcome of Annual General Meeting held on 11th July 2023 (As Per BSE Announcement Dated on 12.07.2023)

AGM Date: 17 Aug 2024

Annual General Meeting of the Company to be held on Saturday 17th August 2024 at 11.00 am through video conference/other audio visual means accordance with the applicable circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. Notice of Annual General Meeting and Annual Report for the financial year 2023-24 Record date for AGM and Dividend is Friday 09th August 2024 The registrar of Members and share transfer books of the Company will be closed from 13th August 2024 to 17th August 2024 for the purpose of holding Annual General Meeting. and the record date is 09th August 2024 for the purpose of AGM and Dividend. (As Per BSE Announcement dated on 23.07.2024) Outcome of 31st Annual General Meeting of the Company. (As Per BSE Announcement dated on 17.08.2024)

AGM Date: 22 Aug 2025

The Board on meeting held today on 29th April 2025 has approved the following. 1. Standalone Audited Financial Results as on 31st March 2025 along with Auditors Report 2. Consolidated Audited Financial Results as on 31st March 2025 along with Auditors Report 3. Other Disclosure/ Announcements. Notice of 32nd Annual General Meeting. (As Per BSE Announcement Dated on: 31/07/2025) 32nd Annual General Meeting of Nath Bio-Genes (India) Limited held today on 22nd August 2025, Pursuant to Regulation 30 and Regulation 44. Please find the following. 1. Proceedings of Annual General Meeting. 2. Voting Results. 3. Scrutinizers Report. (As per BSE Announcement Dated on 22.08.2025)

Nath Bio-Genes (India) Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Hindustan Unilever Ltd	₹2,139.40	₹5,02,671.55
Nestle India Ltd	₹1,421.75	₹2,74,158.09
Varun Beverages Ltd	₹519.75	₹1,75,794.84
Britannia Industries Ltd	₹5,109.50	₹1,23,071.66
Marico Ltd	₹811.15	₹1,05,317.72

Nath Bio-Genes (India) Ltd Top Mutal Funds Invested

No data available

Nath Bio-Genes (India) Ltd News

Board of Nath Bio-Genes (India) recommends final dividend

Of Rs 2 per share

04 May 2026, 05:44 pm

Nath Bio-Genes (India) to declare Quarterly Result & dividend

On 4 May 2026

27 Apr 2026, 02:53 pm

Nath Bio-Genes (India) to conduct board meeting

On 31 January 2026

27 Jan 2026, 10:06 am

Nath Bio-Genes (India) to declare Quarterly Results

On 13 November 2025

10 Nov 2025, 11:22 am

Nath Bio-Genes (India) to announce Quarterly Result

On 11 July 2025

04 Jul 2025, 04:38 pm

Nath Bio-Genes (India) Ltd Stock Analysis

Annual revenue for Nath Bio-Genes (India) Ltd increased by 10.13% to ₹367.04 crore in FY 2025 from ₹333.28 crore in FY 2024.
Annual Net Profit for Nath Bio-Genes (India) Ltd increased by 4.89% to ₹42.14 crore in FY 2025 from ₹40.18 crore in FY 2024.
Promoter Shareholding in Nath Bio-Genes (India) Ltd remains unchanged by 0.00% in the most recent quarter, from 45.60% in December 2025 to 45.60% in March 2026.
Nath Bio-Genes (India) Ltd delivered a 1-year return of -18.87% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Nath Bio-Genes (India) Ltd share price moved up by 1.31% from its previous close of INR ₹165.43. The latest Nath Bio-Genes (India) Ltd share price is INR ₹167.59.
Nath Bio-Genes (India) Ltd share price today has been at a low of 164.80 and a high of 170. Over the past 52 weeks, the Nath Bio-Genes (India) Ltd share price has seen a low of 126.15 and a high of 238.69.